In the proposed study we plan to examine the involvement of plasminogen activator in the process of malignant dissemination and to try to identify factors which might be responsible for a change in malignant phenotype of tumor cells. The role of plasminogen activator will be tested in vivo in two different experimental systems--the chick embryo and the nude mouse. Human carcinoma (HEp3), which produces large amounts of urokinase type plasminogen activator, grows and rapidly and predictably metastasizes into the organs of the chick embryo. We have shown that anti-plasminogen activator antibody substantially reduces, and often prevents, metastasis of this tumor. To determine in which step of tumor dissemination plasminogen activator might play a role, we will continue using the chicken embryo system. In this system, the metastasis is rapid and the disseminating cells are accessible for analysis at any given time. The study will be conducted using histological screening of sections of control and antibody treated tumor-bearing embryos and also, by tracing and spread of radioactively labelled tumor cells. To test the generality of our findings, similar experiments will be performed in another host--the nude mouse, in which this tumor grows and metastasizes. Tumor cells can be found invading locally into the neighboring tissues, the lymphatics, blood vessels and distally to lungs. We plan to examine the effect of antibodies (poly and monoclonals) on the local invasion and metastasis. Another highly metastatic tumor--a human melanoma--which produces exclusively tissue type plasminogen activator will be examined in the same context. The second part of the project will involve the factors which affect malignant phenotype of the HEp3 tumor. We have found that the malignant phenotype is maintained only in vivo and that during growth in cell culture it is progressively reduced to the point of extinction. This is a reversible change; malignancy reappears with prolonged exposure to in vivo conditions. By finding which properties are associated with the malignant and the nonmalignant phenotypes and how the conversion in this system can be affected, we hope to gain some information on the control of expression of malignancy in general. (B)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040758-02
Application #
3181068
Study Section
Pathology B Study Section (PTHB)
Project Start
1985-07-01
Project End
1988-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Graduate Schools
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Franco, Paola; Vocca, Immacolata; Carriero, Maria V et al. (2006) Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin. J Cell Sci 119:3424-34
Wang, Long G; Ossowski, Liliana; Ferrari, Anna C (2004) Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Oncogene 23:5175-84
Aguirre-Ghiso, Julio A; Ossowski, Liliana; Rosenbaum, Sarah K (2004) Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res 64:7336-45
Aguirre Ghiso, Julio A (2002) Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21:2513-24
Liu, David; Aguirre Ghiso, Julio; Estrada, Yeriel et al. (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1:445-57
Aguirre-Ghiso, J A; Liu, D; Mignatti, A et al. (2001) Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12:863-79
Wang, L G; Ossowski, L; Ferrari, A C (2001) Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. Cancer Res 61:7544-51
Ossowski, L; Aguirre-Ghiso, J A (2000) Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12:613-20
Gao, M; Ossowski, L; Ferrari, A C (1999) Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. J Cell Physiol 179:336-46
Aguirre Ghiso, J A; Kovalski, K; Ossowski, L (1999) Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147:89-104

Showing the most recent 10 out of 25 publications